Suchergebnisse - "Hong, Jian"

PubPharm (24)

1

Cigarette Smoke Containing Acrolein Contributes to Cisplatin Resistance in Human Bladder Cancers through the Regulation of HER2 Pathway or FGFR3 Pathway

enthalten in: Molecular cancer therapeutics | 2022

von Hong, J. | Tong, Z. | Wei, T. | +7

2

Molecular mechanisms of platinum‑based chemotherapy resistance in ovarian cancer (Review)

enthalten in: Oncology reports | 2022

von Yang, L. | Xie, H. | Li, Y. | +3

3

Next-Generation Kinase Inhibitors Targeting Specific Biomarkers in Non-Small Cell Lung Cancer (NSCLC) : A Recent Overview

enthalten in: ChemMedChem | 2021

von Das, D. | Wang, J. | Hong, J.

4

Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation

enthalten in: Journal of cellular and molecular medicine | 2021

von Jiang, Y. | Chen, P. | Hu, K. | +12

5

In vivo efficacy studies of novel quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors, in lung cancer xenografts (NCI-H1975) mice models

enthalten in: Bioorganic chemistry | 2020

von Das, D. | Xie, L. | Wang, J. | +2

6

Marrow fibrosis is an independent predictor of hematological toxicity of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia

enthalten in: Leukemia & lymphoma | 2020

von Ni, J. | Hong, J. | Zhang, Z. | +4

7

Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T Cells

enthalten in: Frontiers in immunology | 2020

von Yang, M. | Wang, L. | Ni, M. | +15

8

Design, synthesis of orally bioavailable novel anaplastic lymphoma kinase (ALK) inhibitor diphenylaminopyrimidine analogs and efficacy study on NCI-H2228 xenografts mice model

enthalten in: Bioorganic & medicinal chemistry letters | 2019

von Das, D. | Wang, J. | Li, Y. | +2

9

Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry

enthalten in: European journal of medicinal chemistry | 2019

von Das, D. | Hong, J.

10

Discovery of new quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors and their anticancer activities - Part 1

enthalten in: Bioorganic & medicinal chemistry letters | 2019

von Das, D. | Xie, L. | Wang, J. | +5